Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Net sales and operating profit increased due to the development of high-value-added products, growth in the overseas business and revised shipment prices for certain products, while the Industrial Products Business recorded lower sales and profit following the transfer of shares in 2 chemical products subsidiaries.
There are no applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥325,413 million (YoY +6.7%) |
| Operating profit | ¥31,285 million (YoY +12.4%) |
| Ordinary income | ¥33,772 million (YoY +13.3%) |
| Profit attributable to owners of the parent | ¥17,977 million (YoY -13.6%) |
| Net income per share | ¥64.97 |
| Equity ratio | End of the current fiscal period 63 / End of previous period 61.1 |
| Total assets | ¥532,212 million |
| Net assets | ¥361,445 million |
| Cash flows from operating activities | ¥14,623 million |
| Cash flows from investing activities | ¥-7,974 million |
| Cash flows from financing activities | ¥-16,842 million |
| Cash and cash equivalents at end of period | ¥77,950 million |
| Full-year earnings forecast | Net Sales ¥430,000 million (YoY +1.9%) / Operating profit ¥40,000 million (YoY +10.0%) / Ordinary income Not disclosed / Net income ¥25,000 million (YoY -9.4%) |
| Revision to Earnings Forecast | No |
| Annual Dividend Forecast | ¥30 → ¥34 |
| Segment revenue | Consumer Products Business ¥187,681 million (YoY +0.9%), Industrial Products Business ¥36,076 million (YoY -16.9%), Overseas Business ¥155,014 million (YoY +19.4%), Other ¥6,398 million (YoY -17.4%) |
| Segment profit | Consumer Products Business ¥16,440 million (YoY +3.7%), Industrial Products Business ¥1,722 million (YoY -24.8%), Overseas Business ¥9,951 million (YoY +77.8%), Other ¥30 million |
| Regional sales | ¥99,354 million (YoY +23.4%), ¥55,659 million (YoY +12.8%) |
| Depreciation and amortization | ¥17,117 million |
| Impairment loss | ¥209 million (asset subject to impairment: Not disclosed) |
| Disclosure regarding the going concern assumption | There are no applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New 8 / Name of newly included company PNB Consolidated Pty Ltd and others / Excluded 2 / Excluded Company Name ライオン・スペシャリティ・ケミカルズ㈱, PT. Ipposha Indonesia |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors, securities analysts and others) |
| Issued Shares at Period-End | 279,782,746 shares |
| Treasury Shares at Period-End | 3,081,525 shares |
| Factors Behind Changes in Business Performance | Net sales and operating profit increased due to the development of high-value-added products, growth in the overseas business and revised shipment prices for certain products, while the Industrial Products Business recorded lower sales and profit following the transfer of shares in 2 chemical products subsidiaries. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Despite higher raw material prices and procurement costs resulting from heightened tensions in the Middle East, the Company pursued initiatives including revising shipment prices for certain products, developing high-value-added products and expanding its overseas business. In addition, the transfer of shares in 2 chemical products subsidiaries resulted in lower net sales and profit in the Industrial Products Business.